1 |
Trifan A, Cuciureanu T, Nastasa R, Stratina E, Zenovia S, Muzica CM, Huiban L, Singeap AM, Chiriac S, Sfarti C, Cojocariu C, Girleanu I, Minea H, Stafie R, Rotaru A, Stanciu C. Changes in Components of Metabolic Syndrome after Antiviral Eradication in Hepatitis C Virus Infection. Life (Basel) 2023;13. [PMID: 36836890 DOI: 10.3390/life13020534] [Reference Citation Analysis]
|
2 |
Weigand K, Peschel G, Grimm J, Müller M, Höring M, Krautbauer S, Liebisch G, Buechler C. HCV Infection and Liver Cirrhosis Are Associated with a Less-Favorable Serum Cholesteryl Ester Profile Which Improves through the Successful Treatment of HCV. Biomedicines 2022;10. [PMID: 36551908 DOI: 10.3390/biomedicines10123152] [Reference Citation Analysis]
|
3 |
Peschel G, Grimm J, Müller M, Höring M, Krautbauer S, Weigand K, Liebisch G, Buechler C. Sex-specific changes in triglyceride profiles in liver cirrhosis and hepatitis C virus infection. Lipids Health Dis 2022;21:106. [PMID: 36280840 DOI: 10.1186/s12944-022-01715-w] [Reference Citation Analysis]
|
4 |
Allam AS, Elmeged MLA, Ghaly SM, Ahmed OA, Naguib GG, Abohalima AS. Impact of direct-acting antiviral therapy on metabolic profiles and adiponectin serum level in different categories of patients with chronic hepatitis C infection. Egypt Liver Journal 2022;12. [DOI: 10.1186/s43066-022-00194-z] [Reference Citation Analysis]
|
5 |
Abdel-maksoud HA, Elharrif MG, El-hamid OA, Alsaab SM, El-sorady EM. Monitoring of Iron, Lipid and Liver Profiles in Egyptian Hepatitis C Virus Patients on Sofosbuvir Therapy. Journal of Infection and Public Health 2022. [DOI: 10.1016/j.jiph.2022.01.008] [Reference Citation Analysis]
|